CORRESP Filing
GridAI Technologies Corp.
Date: Sept. 11, 2025 · CIK: 0001604191 · Accession: 0001410578-25-002111
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289864
Letter
Entero Therapeutics, Inc.
777 Yamato Road, Suite 502
Boca Raton, Florida 33431
September 11, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Attn: Jason Drory and Laura Crotty
Re: Entero Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-289864
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Entero Therapeutics, Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 5:15 PM Eastern Time, Monday, September 15, 2025, or as soon as practicable thereafter.
Very truly yours,
By:
/s/ Jason D. Sawyer
Show Raw Text
CORRESP 1 filename1.htm Entero Therapeutics, Inc. 777 Yamato Road, Suite 502 Boca Raton, Florida 33431 September 11, 2025 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attn: Jason Drory and Laura Crotty Re: Entero Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-289864 Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Entero Therapeutics, Inc. hereby respectfully requests acceleration of the effectiveness of the above-referenced Registration Statement so that such Registration Statement will become effective as of 5:15 PM Eastern Time, Monday, September 15, 2025, or as soon as practicable thereafter. Very truly yours, By: /s/ Jason D. Sawyer Jason D. Sawyer Interim Chief Executive Officer